Paloma Partners Management CO Vertex Pharmaceuticals Inc Call Options Transaction History

Paloma Partners Management CO

  • $3.08 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$392.81 - $485.53 $707,058 - $873,954
1,800 New
1,800 $843,000
Q3 2022

Nov 14, 2022
BUY
$273.83 - $305.53 $1.37 Million - $1.53 Million
5,000 New
5,000 $1.45 Million
Q2 2018

Aug 14, 2018
SELL
$145.72 - $169.96 $262,296 - $305,928
-1,800 Reduced 45.0%
2,200 $374,000
Q1 2018

May 15, 2018
BUY
$151.6 - $177.13 $606,400 - $708,520
4,000 New
4,000 $652,000

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email